Cara Therapeutics | CARA - Zahlungsmittel Und Äquivalente

Aktienkurs
2.90
Täglich Wechseln
-0.06 -2.03%
Monatlich
-23.28%
Jährlich
-80.27%
Q2 Prognose
2.82




Zahlungsmittel Und Äquivalente Veränderung Datum
Acadia Pharmaceuticals USD 819.69M 27.33M 2025-12
Alterity Therapeutics Limited AUD 15.77M 9.56M 2023-06
Assertio Holdings USD 38.5M 8.59M 2025-09
Cara Therapeutics USD 21.42M 770K 2025-09
Cassava Sciences USD 106.08M 6.3M 2025-09
Chugai Pharma JPY 456.43B 40.66B 2025-09
Cipla INR 7.96B 39.9M 2025-09
Clal Biotechnology ILS 5.73M 1.71M 2023-12
Compugen USD 90.6M 83.14M 2025-12
CSL USD 2.16B 633M 2025-06
Grifols EUR 979.78M 334.84M 2024-12
Halozyme Therapeutics USD 133.82M 285.84M 2025-12
J&J USD 19.71B 1.48B 2025-12
Neurocrine Biosciences USD 713M 372.8M 2025-12
Pacira USD 158.54M 10.96M 2025-12
Pfizer USD 1.34B 295M 2025-09
RedHill Biopharma USD 2.87M 1.75M 2025-06
Supernus Pharmaceuticals USD 151.37M 6.66M 2025-09
Vanda Pharmaceuticals USD 84.85M 14.83M 2025-12